Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$235M Sell
667,057
-1,011
-0.2% -$360K 0.28% 71
2025
Q4
$219M Sell
668,068
-19,383
-3% -$6.15M 0.26% 77
2025
Q3
$194M Sell
687,451
-22,217
-3% -$6.44M 0.23% 80
2025
Q2
$198M Sell
709,668
-21,405
-3% -$6.06M 0.25% 79
2025
Q1
$228M Sell
731,073
-6,952
-0.9% -$2.05M 0.3% 67
2024
Q4
$192M Sell
738,025
-13,070
-2% -$3.88M 0.25% 77
2024
Q3
$242M Sell
751,095
-7,639
-1% -$2.5M 0.31% 69
2024
Q2
$237M Buy
758,734
+12,103
+2% +$3.56M 0.32% 68
2024
Q1
$212M Buy
746,631
+3,264
+0.4% +$955K 0.3% 71
2023
Q4
$214M Sell
743,367
-40,361
-5% -$11M 0.32% 65
2023
Q3
$207M Buy
783,728
+15,330
+2% +$3.83M 0.34% 63
2023
Q2
$171M Sell
768,398
-17,863
-2% -$4.14M 0.27% 73
2023
Q1
$190M Sell
786,261
-8,973
-1% -$2.2M 0.32% 70
2022
Q4
$209M Buy
795,234
+101,070
+15% +$27.1M 0.37% 64
2022
Q3
$156M Sell
694,164
-6,893
-1% -$1.67M 0.32% 71
2022
Q2
$171M Sell
701,057
-5,518
-0.8% -$1.35M 0.33% 72
2022
Q1
$171M Buy
706,575
+13,382
+2% +$3.07M 0.28% 78
2021
Q4
$156M Buy
693,193
+4,561
+0.7% +$963K 0.25% 89
2021
Q3
$146M Buy
688,632
+10,372
+2% +$2.39M 0.28% 83
2021
Q2
$165M Sell
678,260
-4,424
-0.6% -$1.09M 0.31% 74
2021
Q1
$170M Sell
682,684
-31,107
-4% -$7.42M 0.34% 69
2020
Q4
$164M Buy
713,791
+38,207
+6% +$8.81M 0.35% 67
2020
Q3
$172M Buy
675,584
+6,800
+1% +$1.68M 0.42% 54
2020
Q2
$158M Sell
668,784
-723
-0.1% -$165K 0.41% 57
2020
Q1
$136M Sell
669,507
-4,946
-0.7% -$1.08M 0.42% 59
2019
Q4
$163M Sell
674,453
-28,165
-4% -$6.21M 0.42% 64
2019
Q3
$136M Buy
702,618
+32,083
+5% +$6.16M 0.37% 69
2019
Q2
$124M Buy
670,535
+28,661
+4% +$5.13M 0.34% 72
2019
Q1
$122M Sell
641,874
-14,439
-2% -$2.76M 0.35% 72
2018
Q4
$128M Sell
656,313
-3,596
-0.5% -$702K 0.41% 63
2018
Q3
$137M Sell
659,909
-11,180
-2% -$2.2M 0.4% 65
2018
Q2
$124M Sell
671,089
-8,169
-1% -$1.44M 0.38% 66
2018
Q1
$116M Sell
679,258
-22,616
-3% -$4.15M 0.36% 70
2017
Q4
$122M Sell
701,874
-4,587
-0.6% -$812K 0.37% 68
2017
Q3
$132M Sell
706,461
-12,156
-2% -$2.15M 0.42% 61
2017
Q2
$124M Sell
718,617
-29,303
-4% -$4.77M 0.41% 65
2017
Q1
$123M Sell
747,920
-22,597
-3% -$3.75M 0.42% 64
2016
Q4
$113M Buy
770,517
+28,399
+4% +$4.27M 0.41% 67
2016
Q3
$124M Buy
742,118
+18,663
+3% +$3.16M 0.46% 58
2016
Q2
$110M Buy
723,455
+44,017
+6% +$6.84M 0.42% 61
2016
Q1
$102M Buy
679,438
+43,661
+7% +$6.49M 0.4% 62
2015
Q4
$103M Buy
635,777
+9,956
+2% +$1.56M 0.42% 61
2015
Q3
$86.6M Buy
625,821
+9,735
+2% +$1.53M 0.36% 69
2015
Q2
$94.6M Sell
616,086
-7,958
-1% -$1.27M 0.37% 64
2015
Q1
$99.8M Buy
624,044
+3,348
+0.5% +$527K 0.38% 62
2014
Q4
$98.9M Buy
620,696
+347
+0.1% +$54.1K 0.38% 60
2014
Q3
$87.1M Buy
620,349
+168
+0% +$21.9K 0.35% 59
2014
Q2
$73.4M Sell
620,181
-23,872
-4% -$2.76M 0.29% 75
2014
Q1
$79.4M Buy
644,053
+34,932
+6% +$4.24M 0.33% 63
2013
Q4
$69.5M Buy
609,121
+10,501
+2% +$1.19M 0.28% 77
2013
Q3
$67M Buy
598,620
+6,270
+1% +$680K 0.3% 74
2013
Q2
$58.4M Buy
+592,350
New +$61.5M 0.27% 79

Other funds holding AMGN

US Bancorp's AMGN Position: Q1 2026 in Review

US Bancorp reduced its Amgen (AMGN) stake by 0.15% in Q1 2026, selling an estimated $360K and leaving 667,057 shares worth $235M. The position accounts for 0.28% of the portfolio, ranked #71.

US Bancorp first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $242M in Q3 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • US Bancorp held 667,057 shares of Amgen worth $235M as of Q1 2026.
  • US Bancorp sold 1,011 Amgen shares in Q1 2026, an estimated $360K.
  • Amgen made up 0.28% of US Bancorp's portfolio in Q1 2026, its #71 holding.
  • US Bancorp first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • US Bancorp's Amgen position peaked at $242M in Q3 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.